Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Diabetes Center, Department of Medicine, University of California, San Francisco, San Francisco, California, USA. mhebrok@diabetes.ucsf.edu
Despite intensive research, a treatment for diabetic patients that completely restores normoglycemia for an indefinite period of time remains elusive. Although islet transplantation temporarily confers normoglycemia to patients, the lack of a renewable source of insulin-producing β cells hampers the use of this treatment option. Although significant hurdles remain, recent advances in stem cell biology indicate that generation of fully matured β cells from uncommitted progenitor cells, including human embryonic stem cells and induced pluripotent stem cells derived from somatic cell populations, is becoming an achievable goal.
Images from this publication.See all images (2)Free text
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on